NASDAQ: STRMStreamline Health Solutions Inc Stock
$0.79-0.03 (-3.66%)
Updated Sep 26, 2023
STRM Price
$0.79
Fair Value Price
$0.90
Market Cap
$46.53M
52 Week Low
$0.68
52 Week High
$2.35
P/E
-3.95x
P/B
1.5x
P/S
3.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.06M
Earnings
-$10.74M
Gross Margin
47.2%
Operating Margin
-40.2%
Profit Margin
-44.6%
Debt to Equity
0.71
Operating Cash Flow
-$5M
Beta
0.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
STRM Overview
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STRM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
STRM ($0.79) is undervalued by 11.94% relative to our estimate of its Fair Value price of $0.90 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
STRM ($0.79) is not significantly undervalued (11.94%) relative to our estimate of its Fair Value price of $0.90 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
STRM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more STRM due diligence checks available for Premium users.
Be the first to know about important STRM news, forecast changes, insider trades & much more!
STRM News
Valuation
STRM fair value
Fair Value of STRM stock based on Discounted Cash Flow (DCF)
Price
$0.79
Fair Value
$0.90
Undervalued by
11.94%
STRM ($0.79) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
STRM ($0.79) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
STRM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
STRM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.95x
Industry
55.14x
Market
14.06x
STRM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.5x
Industry
3.07x
STRM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
STRM's financial health
Profit margin
Revenue
$5.8M
Net Income
-$2.5M
Profit Margin
-43.6%
STRM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STRM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$53.3M
Liabilities
$22.2M
Debt to equity
0.71
STRM's short-term liabilities ($13.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STRM's long-term liabilities ($8.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STRM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
STRM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.1M
Investing
-$640.0k
Financing
-$198.0k
STRM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
STRM vs Health Information Service Stocks
Streamline Health Solutions Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.